InvestorsHub Logo
Followers 45
Posts 17641
Boards Moderated 0
Alias Born 09/16/2012

Re: JerryCampbell post# 191237

Tuesday, 09/25/2018 2:26:07 PM

Tuesday, September 25, 2018 2:26:07 PM

Post# of 721600
What about the need to increase the authorized/ outstanding to cover the conversion to common? Original common shareholders own less and less of the pie. And it likely stymies the share price run.

Of course in biotech where an FDA approval means sometimes hundreds X gain, that may not be so bad but it's still dilution.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News